Karine Souza Da Correggio

Dr. Karine Souza Da Correggio


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2024 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
KCKarine Souza Da Correggio
Karine Souza Da Correggio
RGRoberto Noya Galluzzo
Roberto Noya Galluzzo
Aldo von WangenheimAldo von Wangenheim
Aldo von Wangenheim
HWHeron Werner
Heron Werner
PCPedro Teixeira Castro
Pedro Teixeira Castro
AOAlexandre Sherlley Casimiro Onofre
Alexandre Sherlley Casimiro Onofre

1 November 2021 in Placenta
Verified
Journal Article
Closed access
KCKarine Souza Da Correggio
Karine Souza Da Correggio
SSSheila Koettker Silveira
Sheila Koettker Silveira
OFOtto Henrique May Feuerschuette
Otto Henrique May Feuerschuette
FMFlora Troina Maraslis
Flora Troina Maraslis
KPKamylla Pinheiro
Kamylla Pinheiro
AOAlexandre Sherlley Casimiro Onofre
Alexandre Sherlley Casimiro Onofre

8 August 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
RGRoberto noya Galluzzo
Roberto noya Galluzzo
KCKarine Souza Da Correggio
Karine Souza Da Correggio
Aldo von WangenheimAldo von Wangenheim
Aldo von Wangenheim
GCGustavo Yano Callado
Gustavo Yano Callado
HWHeron Werner
Heron Werner
AOAlexandre Sherlley Casimiro Onofre
Alexandre Sherlley Casimiro Onofre
Objective: To investigate the association between prenatal ultrasonographic markers of macrossomia and C-peptide, a neonatal hyperinsulinemia marker, in pregnancies complicated by gestational diabetes mellitus (GDM), with a focus on fetal adipose tissue thickness, liver length, and interventricular septal thickness. Methods: This prospective cohort study included 223 pregnant women followed from 28 to 36 weeks of gestation in two referral centers in Brazil. The GDM group and matched controls underwent serial ultrasound assessments of fetal biometry, including thigh, abdominal, and subscapular skinfolds, fetal liver length, and interventricular septum thickness. Neonatal hyperinsulinemia was assessed using umbilical cord C-peptide levels. Statistical analyses included t-tests, chi-square tests, correlation analyses, and multivariate logistic regression. Results: Fetuses of mothers with GDM exhibited significantly greater abdominal [t(221) = −3.999, p < 0.01] and subscapular [t(221) = −2.502, p = 0.02] skinfolds, liver length [t(221) = −3.785, p < 0.01], and interventricular septum [t(221) = −4.781, p < 0.01] thickness. However, umbilical cord C-peptide levels did not differ significantly between groups [t(189) = −1.724, p = 0.09]. Only weak correlations were found between fetal ultrasound markers and C-peptide levels. Among all parameters, subcutaneous tissue thickness showed the highest (ρ = 0.30), though still limited, predictive value. Conclusions: Fetuses of mothers with GDM demonstrated increased measures of liver length, subscapular adiposity, and interventricular septal thickness compared to controls. However, these prenatal biometric markers showed weak correlations with neonatal C-peptide levels.

8 September 2025 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
KCKarine Souza Da Correggio
Karine Souza Da Correggio
LSLuís Otávio Santos
Luís Otávio Santos
FBFelipe S Muylaert Barroso
Felipe S Muylaert Barroso
RGRoberto N Galluzzo
Roberto N Galluzzo
TCThiago Z L Chaves
Thiago Z L Chaves
AOAlexandre S C Onofre
Alexandre S C Onofre
Objectives: To evaluate the performance of artificial intelligence (AI)‐based models in predicting elevated neonatal insulin levels through fetal hepatic echotexture analysis. Methods: This diagnostic accuracy study analyzed ultrasound images of fetal livers from pregnancies between 37 and 42 weeks, including cases with and without gestational diabetes mellitus (GDM). Images were stored in Digital Imaging and Communications in Medicine (DICOM) format, annotated by experts, and converted to segmented masks after quality checks. A balanced dataset was created by randomly excluding overrepresented categories. Artificial intelligence classification models developed using the FastAI library—ResNet‐18, ResNet‐34, ResNet‐50, EfficientNet‐B0, and EfficientNet‐B7—were trained to detect elevated C‐peptide levels (>75th percentile) in umbilical cord blood at birth, based on fetal hepatic ultrasonographic images. Results: Out of 2339 ultrasound images, 606 were excluded due to poor quality, resulting in 1733 images analyzed. Elevated C‐peptide levels were observed in 34.3% of neonates. Among the 5 CNN models evaluated, EfficientNet‐B0 demonstrated the highest overall performance, achieving a sensitivity of 86.5%, specificity of 82.1%, positive predictive value (PPV) of 83.0%, negative predictive value (NPV) of 85.7%, accuracy of 84.3%, and an area under the ROC curve (AUC) of 0.83 in predicting elevated neonatal insulin levels through fetal hepatic echotexture analysis. Conclusion: AI‐based analysis of fetal liver echotexture via ultrasound effectively predicted elevated neonatal C‐peptide levels, offering a promising non‐invasive method for detecting insulin imbalance in newborns.

25 August 2026 in Journal of Perinatal Medicine
Verified
Journal Article
Open access
RGRoberto Noya Galluzzo
Roberto Noya Galluzzo
KCKarine Souza Da Correggio
Karine Souza Da Correggio
Aldo von WangenheimAldo von Wangenheim
Aldo von Wangenheim
HWHeron Werner
Heron Werner
Edward Araujo JúniorEdward Araujo Júnior
Edward Araujo Júnior
AOAlexandre Sherlley Casimiro Onofre
Alexandre Sherlley Casimiro Onofre
Objectives: Gestational diabetes mellitus (GDM) is associated with fetal hyperinsulinemia, excessive adiposity, and adverse perinatal outcomes; sonographic markers of fetal adiposity, liver enlargement, and septal thickening may allow direct assessment of fetal metabolic adaptation. This study aimed to develop an ultrasound-based fetal metabolic score (FMS) estimating the risk of fetal hyperinsulinemia. Methods: The FMS was developed from a prospective cohort of 223 pregnant women (128 with GDM, 95 controls). Sonographic markers of neonatal hyperinsulinemia were identified using umbilical cord C-peptide above the 75th percentile as the reference outcome: thigh soft tissue thickness, abdominal subcutaneous fat thickness, fetal liver length, and interventricular septal thickness. Odds ratios from logistic regression were converted into weighted integer coefficients, and continuous measurements were categorized by gestational age-adjusted percentiles into a composite score. Results: Fetuses of GDM mothers showed significantly greater abdominal adiposity, liver length, and interventricular septal thickness than controls. Thigh soft tissue thickness (OR 1.62; 95 % CI 1.25–2.09; p<0.001), abdominal subcutaneous fat thickness (OR 1.57; 95 % CI 1.23–1.99; p<0.001), fetal liver length (OR 1.06; 95 % CI 1.02–1.11; p=0.004), and interventricular septal thickness (OR 1.35; 95 % CI 1.01–1.82; p=0.040) independently predicted elevated cord blood C-peptide. The FMS ranged from 0 to 44 points, integrating weighted contributions from adiposity, visceral growth, and cardiac remodeling markers. Conclusions: The FMS is a novel ultrasound-based approach for estimating fetal hyperinsulinemia risk. By integrating multiple manifestations of the fetal metabolic response to maternal hyperglycemia, it may assess fetal metabolic health more comprehensively than conventional biometry alone.